IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.212
NA - Nord America 5.084
AS - Asia 3.131
SA - Sud America 540
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 14.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.926
RU - Federazione Russa 1.373
IE - Irlanda 1.084
SG - Singapore 935
CN - Cina 857
DE - Germania 698
SE - Svezia 550
HK - Hong Kong 455
VN - Vietnam 433
BR - Brasile 418
UA - Ucraina 418
IT - Italia 346
FI - Finlandia 261
FR - Francia 208
IN - India 156
GB - Regno Unito 118
CA - Canada 101
AR - Argentina 45
MX - Messico 42
BD - Bangladesh 37
IR - Iran 36
KR - Corea 36
PL - Polonia 35
ID - Indonesia 33
ZA - Sudafrica 33
BJ - Benin 30
TR - Turchia 28
JP - Giappone 27
BE - Belgio 23
ES - Italia 22
EC - Ecuador 19
IQ - Iraq 18
AT - Austria 15
LT - Lituania 15
PK - Pakistan 15
CL - Cile 14
CO - Colombia 14
NL - Olanda 14
EG - Egitto 12
UZ - Uzbekistan 11
PY - Paraguay 10
VE - Venezuela 10
MA - Marocco 9
TN - Tunisia 9
EU - Europa 8
RO - Romania 8
PH - Filippine 7
SA - Arabia Saudita 7
AL - Albania 6
JO - Giordania 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
HR - Croazia 4
IL - Israele 4
PA - Panama 4
PE - Perù 4
CH - Svizzera 3
ET - Etiopia 3
HN - Honduras 3
KE - Kenya 3
NG - Nigeria 3
TH - Thailandia 3
AU - Australia 2
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
HU - Ungheria 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
OM - Oman 1
RE - Reunion 1
SN - Senegal 1
Totale 14.090
Salva come PNG Salva come JPEG
Città #
Dublin 1.076
Jacksonville 750
San Jose 477
Hong Kong 452
Dearborn 412
Singapore 366
Ashburn 333
Beijing 270
New York 241
Chandler 217
Wilmington 186
Moscow 165
Ho Chi Minh City 149
Ann Arbor 147
Los Angeles 144
Lauterbourg 141
Lawrence 134
Princeton 134
Piemonte 104
Hanoi 95
San Mateo 90
Andover 84
Munich 83
Buffalo 72
Toronto 58
São Paulo 53
Bremen 50
Grafing 49
Orem 48
Santa Clara 42
Novara 40
Dallas 35
Seoul 34
Frankfurt am Main 33
Redondo Beach 32
Cotonou 30
Helsinki 28
Council Bluffs 27
Denver 27
Tokyo 25
Chennai 24
Warsaw 24
Atlanta 23
Houston 23
Guangzhou 22
Haiphong 22
Montreal 22
Stockholm 22
Brooklyn 21
Leawood 21
London 21
Nanjing 21
Brussels 20
Hefei 20
Mexico City 20
Cave Creek 19
Chicago 18
Monmouth Junction 18
Tianjin 18
Woodbridge 18
Zanjan 18
Da Nang 16
Hangzhou 16
Johannesburg 16
Manchester 16
Boardman 15
Kunming 15
Norwalk 15
Poplar 15
Biên Hòa 14
Mumbai 14
Nuremberg 14
Rio de Janeiro 14
Augusta 12
Kocaeli 11
Milan 11
Phoenix 11
Seattle 11
Shanghai 11
Curitiba 10
Jinan 10
Tashkent 10
Turku 10
Ankara 9
Ardabil 9
Bexley 9
Boston 9
Fairfield 9
Hải Dương 9
Jakarta 9
Ninh Bình 9
Turin 9
Amsterdam 8
Hebei 8
Lahore 8
Quito 8
Rome 8
San Francisco 8
Vienna 8
Wroclaw 8
Totale 7.800
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 165
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 156
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 152
195Pt NMR chemical shift: a chemometric approach 146
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 146
Transition metal carbonyl clusters in biology: A futile or niche research area? 143
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 142
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 138
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 138
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 136
A different way for the oxidation of the Pt(II) complexes 135
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 135
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 134
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 134
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 133
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 131
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 131
Different strategies to exploit Pt(IV) complexes as pro-drugs 130
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 130
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 130
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 130
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 128
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 128
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 125
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 125
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 125
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 124
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 123
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 121
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 121
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 121
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 120
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 120
A view on multi-action Pt(IV) antitumor prodrugs 120
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 118
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 114
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 112
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 111
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 111
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 111
Pt-195 NMR spectroscopy: A chemometric approach 109
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 109
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 109
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 108
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 108
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 107
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 106
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 103
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 102
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 102
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 101
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 100
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 100
Pt(IV) complexes as anticancer prodrugs 100
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 100
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 100
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 99
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 99
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 99
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 98
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 97
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 97
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 95
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 95
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 94
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 94
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 91
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 90
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 90
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 90
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 89
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 88
Experimental determination and modeling of the lipophilicity in platinum complexes 85
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 85
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 84
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 84
Targeting and delivery of Pt(II) antiproliferative drugs 82
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 81
Ethynylestradiol-Pt(II) complexes for selective drug targeting 80
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 80
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 80
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 80
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 79
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 79
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 78
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 77
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 77
Platinum Complexes With Substituted Phosphines: Synthesis, Characterization, And Antiproliferative Activity 77
Rhein to impart antimetastatic features to Pt(IV) complexes and to target brain 76
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 76
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 76
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 76
Totale 10.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 0 0 0 0 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20265.844 338 276 470 941 553 420 793 1.006 426 395 226 0
Totale 14.270